Ravn V, Mandel U, Svenstrup B, Dabelsteen E
Department of Pathology, Rigshospitalet, University of Copenhagen, Denmark.
Virchows Arch. 1994;424(4):411-9. doi: 10.1007/BF00190564.
Changes in expression of histo-blood group ABH and Lewis antigens are common alterations in carcinomas. Using immunohistochemistry, we have evaluated the expression of type-2 histo-blood group antigens in normal and malignant endometrial tissues in relation to genetic and hormonal factors. The Le(x), sialosyl-Le(x), and Le(y) antigens were inconstantly expressed in the normal endometrium. The expression was uninfluenced by the secretor status but was related to the ABO blood group status in Oestradiol (E2) stimulated endometria. Le(y) was expressed most frequently in proliferating endometria from blood group 0 individuals. Le(x) and Le(y) were maximally expressed in atrophic endometria, and Le(x) and Le(y) staining scores correlated inversely with serum levels of E2 in normal, non-secretory endometria. No correlation was found in adenomatous hyperplasias and endometrial carcinomas, which when compared with atrophic endometria, showed a loss of Le(x) and Le(y) and an increased H-carbohydrate expression at apical membranes. Carcinomas from non-secretors showed lower expression of Le(y) and H-antigens than carcinomas from secretors. Our findings suggest that the genetic and hormonal influence on glycosylation based on type-2 chain carbohydrates differ between normal and malignant endometrium. This difference is probably related to specific tumour-associated qualitative and quantitative changes in the fucosyltransferases.
组织血型ABH和Lewis抗原的表达变化是癌症中常见的改变。我们运用免疫组织化学方法,评估了2型组织血型抗原在正常和恶性子宫内膜组织中的表达,并探讨了其与遗传和激素因素的关系。Le(x)、唾液酸化Le(x)和Le(y)抗原在正常子宫内膜中的表达不稳定。其表达不受分泌者状态的影响,但在雌二醇(E2)刺激的子宫内膜中与ABO血型状态相关。Le(y)在血型为O的个体的增殖期子宫内膜中表达最为频繁。Le(x)和Le(y)在萎缩性子宫内膜中表达最高,且在正常、非分泌期子宫内膜中,Le(x)和Le(y)染色评分与血清E2水平呈负相关。在腺瘤样增生和子宫内膜癌中未发现相关性,与萎缩性子宫内膜相比,腺瘤样增生和子宫内膜癌顶端膜处的Le(x)和Le(y)表达缺失,H碳水化合物表达增加。非分泌者的癌组织中Le(y)和H抗原的表达低于分泌者的癌组织。我们的研究结果表明,正常和恶性子宫内膜中基于2型链碳水化合物的糖基化的遗传和激素影响存在差异。这种差异可能与岩藻糖基转移酶中特定的肿瘤相关定性和定量变化有关。